Navigation Links
Osteotech Reports First Quarter 2009 Financial Results
Date:4/30/2009

1, 2009 was $1.8 million, or $0.10 per diluted share, compared with net income of $808,000, or $0.05 per diluted share, for the first quarter of 2008.

"Looking ahead, we are well positioned to launch or unveil MagniFuse, Plexur M, DuraTech and Facetlinx(TM) Facet Fusion Graft, our procedure-specific spine product, and we believe we are taking the steps necessary, particularly within our sales distribution network, to encourage demand," continued Mr. Owusu-Akyaw. "Based upon the investments we have made in our business and the emerging trends in orthopedics, we believe we are well positioned to emerge as a leader in the industry. We believe our proprietary technology platforms and research and development capabilities provide us with a technology lead that will be difficult to penetrate. We remain focused on increasing shareholder value and believe that the potential for sustainable, profitable revenue growth will allow us to reach our goal of providing significant returns to all of our stakeholders."

Guidance

Based upon the results achieved to date, Osteotech is reiterating the financial guidance it has previously established for 2009:

  • Overall revenue is expected to range between $96 million and $100 million;
  • Net loss for 2009 is expected to be between $0.05 and $0.07 per share; the Company remains on track to generate free cash flow from operations in 2009; and
  • The Company expects to exit 2009 with approximately $15 million in cash.

Conference Call Tomorrow, May 1, 2009

The Osteotech management team will host a conference call on May 1, 2009 at 9:00 a.m. (EDT) to discuss first quarter 2009 financial results, recent corporate developments and guidance for 2009. The conference call may be accessed by dialing 1-866-783-2141 (domestic) or 1-857-350-1600 (international) and indica
'/>"/>

SOURCE Osteotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Osteotech to Present at Roth Capital Partners 2007 New York Investor Conference
2. Osteotech to Present at Sidoti Conference in San Francisco
3. Osteotech Announces Fourth Quarter and Full Year Earnings Release and Conference Call Schedule
4. Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007
5. Osteotech to Present at the Canaccord Adams Small-Cap Orthopedics Conference in San Francisco
6. Osteotech Receives FDA Clearance for Plexur M(TM) Biocomposite
7. Osteotech to Present at the Sidoti Conference in New York
8. U.S. Patent Office Confirms Validity of Osteotechs U.S. Patent No. 5,676,146
9. Osteotech Announces First Quarter Earnings Release and Conference Call Schedule
10. Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance
11. Osteotechs Plexur P(TM) Receives FDA Clearance as Bone Void Filler and Bone Graft Extender in Spine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... (PRWEB) August 21, 2014 His Majesty ... Opening , The Court of His Majesty Willem-Alexander, King ... attend the Grand Opening of POET-DSM Advanced Biofuels’ Project ... Sept. 3. , The King will take part in ... activity, scheduled for 11 a.m.-12:20 p.m. and tour the ...
(Date:8/21/2014)... , Aug. 21, 2014  Decision Resources Group ... Brazil and Mexico ... of several newly approved agents, the anticipated label ... and the launch of emerging biologics will substantially ... particular, the emerging IL-5 inhibitors will introduce a ...
(Date:8/21/2014)... , Aug. 21, 2014  China Cord Blood Corporation ... its plan to release financial results for the first ... 2014, after market close in the US.  ... 8:00 a.m. ET on Friday, August 29, 2014 to ... of the Company,s recent developments, followed by a question ...
(Date:8/21/2014)... August 21, 2014 Ontotext S4 ... by Ontotext . Now the same enterprise ... of structured and unstructured data is available to start-ups ... of enterprise technology. Organizations that do not have resources ... management can use S4 since there is no need ...
Breaking Biology Technology:His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 2His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 3Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 2Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 3China Cord Blood Corporation to Report First Quarter of Fiscal 2015 Financial Results 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 3Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 4
... NEW YORK , May 28 ... an international biopharmaceutical company,with operations in the U.S. and China , ... , BSN, RN, HP (ASCP), has been,selected to present at the American ... . , , , ...
... A research ... gene transfer from host to parasite plant species. The discovery, reported in Science this week, ... ... A research team at RIKEN, Japan’s flagship research organization, has uncovered the first ever evidence ...
... May 27 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc. (NYSE,Amex: ... operations in the U.S. and China , announced that ... technologies at the Stem Cell,Investor & Executive Networking Conference Event ... 2010 . SCIENCE is designed to bring together investors with ...
Cached Biology Technology:NeoStem Selected to Present at American Society for Apheresis 2NeoStem Selected to Present at American Society for Apheresis 3NeoStem Selected to Present at American Society for Apheresis 4Parasite plants rob genes from their hosts 2NeoStem's Advanced Adult Stem Cell Technology to be Featured at Upcoming Conference 2NeoStem's Advanced Adult Stem Cell Technology to be Featured at Upcoming Conference 3NeoStem's Advanced Adult Stem Cell Technology to be Featured at Upcoming Conference 4NeoStem's Advanced Adult Stem Cell Technology to be Featured at Upcoming Conference 5
(Date:8/21/2014)... Nine researchers from Beth Israel Deaconess Medical Center ... "The World,s Most Influential Scientific Minds 2014," a ... ScienceWatch, a web resource for science metrics and research ... among the most influential "are performing and publishing work ... of their science," according to a Thomson Reuters statement. ...
(Date:8/21/2014)... in the journal Carcinogenesis by researchers at ... the protein adenomatous polyposis coli (APC) in suppressing colorectal ... the U.S. , Lead author Kristi Neufeld, associate professor ... the Cancer Biology program at the KU Cancer Center, ... to understand the various activities of APC, a protein ...
(Date:8/21/2014)... Acute pancreatitis involves the pancreas digesting itself resulting in ... in the UK around 20,000 patients are diagnosed with ... immediate cure and treatment is restricted to intravenous fluid ... the Faculty of Life Sciences, who led the research, ... reflux from gall stones and excessive alcohol intake combined ...
Breaking Biology News(10 mins):BIDMC researchers named among 'the most influential scientific minds' 2BIDMC researchers named among 'the most influential scientific minds' 3Research offers insight into cellular biology of colorectal cancer 2Research offers insight into cellular biology of colorectal cancer 3Insulin offers new hope for the treatment of acute pancreatitis 2
... Scientists at The University of Nottingham and the Wellcome Trust ... that control the three key stages in the life cycle ... third of these switches can be disrupted in some way. ... and the Medical Research Council (MRC) is a significant breakthrough ...
... journal, Science Translational Medicine , examines the structures ... commentary has been written by researchers from the National ... (BRC) at Guy,s and St Thomas, and King,s College ... Government and charitable investment in translational research taking place ...
... Health Sciences Center New Orleans has been awarded $12 ... Health to conduct research on diseases like prostate and ... herpes infections, as well as to support the development ... round of funding for a $10.6 million Center of ...
Cached Biology News:Malaria research begins to bite 2Malaria research begins to bite 3Strategies for translational research in the UK 2LSUHSC awarded $12 million for cancer, infectious diseases research & research pipeline 2LSUHSC awarded $12 million for cancer, infectious diseases research & research pipeline 3
GOAT ANTI HUMAN FACTOR 8RELATED ANTIGEN...
2,4,6-Trinitrophenyl hapten is conjugated to Bovine Serum Albumin protein through lysine by amide bonds....
EoProbe Eosinophil Staining Kit, 1 Kit...
B.D. Hames and D.M. Glover (1996) • This issue covers T-Cell antigen receptor genes; T-Lymphocyte signal transduction; B-Cell activation antibody engineering and the complement system and other ...
Biology Products: